Market Closed -
Euronext Paris
16:35:17 26/04/2024 BST
|
5-day change
|
1st Jan Change
|
20.8
EUR
|
+3.23%
|
|
+8.45%
|
-25.85%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
22
|
65.36
|
320
|
417.2
|
383.4
|
350.1
|
350.1
|
-
|
Enterprise Value (EV)
1 |
18.72
|
53.27
|
296.5
|
332.2
|
327.5
|
472.1
|
357.1
|
450.9
|
P/E ratio
|
-7.1
x
|
-17.6
x
|
-52.1
x
|
107
x
|
-13.9
x
|
-10.9
x
|
-14.5
x
|
-9.83
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
20.3
x
|
45.1
x
|
195
x
|
3,973
x
|
5,477
x
|
19,670
x
|
20
x
|
5.63
x
|
EV / Revenue
|
17.3
x
|
36.7
x
|
180
x
|
3,164
x
|
4,679
x
|
19,670
x
|
20.4
x
|
7.25
x
|
EV / EBITDA
|
-4.78
x
|
-12.6
x
|
-46.6
x
|
57.1
x
|
-15.8
x
|
-8.64
x
|
-16.9
x
|
-25.8
x
|
EV / FCF
|
-5.54
x
|
-9.98
x
|
-16.5
x
|
-15.9
x
|
-10.2
x
|
-2.75
x
|
-3.21
x
|
-4.81
x
|
FCF Yield
|
-18%
|
-10%
|
-6.05%
|
-6.27%
|
-9.84%
|
-36.4%
|
-31.2%
|
-20.8%
|
Price to Book
|
1.84
x
|
2.49
x
|
6.51
x
|
2.85
x
|
3.06
x
|
1.52
x
|
1.74
x
|
2
x
|
Nbr of stocks (in thousands)
|
4,622
|
6,895
|
8,080
|
11,161
|
11,205
|
16,830
|
16,830
|
-
|
Reference price
2 |
4.760
|
9.480
|
39.60
|
37.38
|
34.22
|
20.80
|
20.80
|
20.80
|
Announcement Date
|
08/04/19
|
16/03/20
|
06/04/21
|
01/04/22
|
06/04/23
|
11/04/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
1.083
|
1.45
|
1.643
|
0.105
|
0.07
|
0.024
|
17.5
|
62.17
|
EBITDA
1 |
-3.915
|
-4.213
|
-6.368
|
5.82
|
-20.67
|
-25.42
|
-21.08
|
-17.5
|
EBIT
1 |
-4.24
|
-4.535
|
-6.821
|
-15.85
|
-26.1
|
-28.88
|
-27.38
|
-26.65
|
Operating Margin
|
-391.51%
|
-312.76%
|
-415.16%
|
-15,093.33%
|
-37,287.14%
|
-120,325%
|
-156.43%
|
-42.87%
|
Earnings before Tax (EBT)
1 |
-4.302
|
-4.549
|
-7.634
|
4.908
|
-27.74
|
-27.22
|
-31.45
|
-19.2
|
Net income
1 |
-3.11
|
-3.749
|
-6.146
|
3.78
|
-27.74
|
-27.22
|
-24.75
|
-36.2
|
Net margin
|
-287.17%
|
-258.55%
|
-374.07%
|
3,600%
|
-39,630%
|
-113,433.33%
|
-141.43%
|
-58.23%
|
EPS
2 |
-0.6700
|
-0.5400
|
-0.7600
|
0.3500
|
-2.470
|
-1.910
|
-1.430
|
-2.117
|
Free Cash Flow
1 |
-3.377
|
-5.335
|
-17.94
|
-20.84
|
-32.24
|
-79.88
|
-111.4
|
-93.82
|
FCF margin
|
-311.82%
|
-367.93%
|
-1,091.97%
|
-19,847.62%
|
-46,057.14%
|
-4,630.43%
|
-636.38%
|
-150.92%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
08/04/19
|
16/03/20
|
06/04/21
|
01/04/22
|
06/04/23
|
11/04/24
|
-
|
-
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
7
|
101
|
Net Cash position
1 |
3.28
|
12.1
|
23.5
|
85
|
55.9
|
130
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-0.3321
x
|
-5.76
x
|
Free Cash Flow
1 |
-3.38
|
-5.34
|
-17.9
|
-20.8
|
-32.2
|
-79.9
|
-111
|
-93.8
|
ROE (net income / shareholders' equity)
|
-23.4%
|
-17.9%
|
-18.3%
|
-18.2%
|
-20.4%
|
-15.2%
|
-4.9%
|
-19.8%
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
2 |
2.580
|
3.800
|
6.080
|
13.10
|
11.20
|
13.70
|
11.90
|
10.40
|
Cash Flow per Share
2 |
-0.6600
|
-0.4400
|
-0.6400
|
-0.8400
|
-1.950
|
-2.380
|
-5.040
|
-4.580
|
Capex
1 |
0.3
|
2.3
|
12.8
|
11.8
|
10.4
|
52.7
|
104
|
72.4
|
Capex / Sales
|
27.61%
|
158.55%
|
777.36%
|
11,234.29%
|
14,885.71%
|
3,052.17%
|
592.57%
|
116.38%
|
Announcement Date
|
08/04/19
|
16/03/20
|
06/04/21
|
01/04/22
|
06/04/23
|
11/04/24
|
-
|
-
|
Last Close Price
20.8
EUR Average target price
58.5
EUR Spread / Average Target +181.25% Consensus |
1st Jan change
|
Capi.
|
---|
| -25.85% | 374M | | +5.14% | 103B | | -1.80% | 65.6B | | +39.52% | 39.06B | | +12.91% | 37.58B | | +7.41% | 33.26B | | +6.85% | 19.22B | | +12.86% | 16.83B | | +7.73% | 15.03B | | +16.93% | 14.96B |
Other Commodity Chemicals
|